Gliclazide IP (40 mg), Metformin Hydrochloride IP (500 mg), Voglibose IP (0.3 mg) – GLICLAGLAZE TRIO 40/0.3 Complete Guide

What is GLICLAGLAZE TRIO 40/0.3 for?

GLICLAGLAZE TRIO 40/0.3, from Steris Healthcare, is a prescription combination containing Gliclazide IP 40 mg, Metformin Hydrochloride IP 500 mg, and Voglibose IP 0.3 mg. It is used for the management of type 2 diabetes mellitus when blood-glucose control is not adequately achieved through lifestyle measures or simpler treatment regimens.

Each ingredient works through a different pathway. Gliclazide stimulates insulin release from pancreatic beta cells, metformin reduces glucose production by the liver and improves insulin sensitivity, while voglibose delays carbohydrate digestion and helps reduce post-meal glucose spikes.

Why This Combination Is Important

Type 2 diabetes can involve insulin resistance, increased hepatic glucose production, insufficient insulin secretion, and elevated post-meal blood glucose. A combination treatment may address several of these factors simultaneously.

GLICLAGLAZE TRIO 40/0.3 combines insulin-secretagogue activity with improved insulin sensitivity and delayed carbohydrate absorption. This complementary approach can help appropriate patients achieve individualized blood-glucose targets when prescribed by a healthcare professional.

Treatment should be supported by a balanced diet, regular physical activity, appropriate weight management, and blood-glucose monitoring.

Key Benefits of GLICLAGLAZE TRIO 40/0.3

What are the benefits?

  • Helps control blood glucose in appropriate patients with type 2 diabetes.
  • Supports insulin secretion through gliclazide.
  • Improves insulin sensitivity through metformin.
  • Reduces hepatic glucose production through metformin.
  • Helps control post-meal glucose elevations through voglibose.
  • Provides three complementary mechanisms in one prescribed treatment.

Mechanism of Action

Gliclazide stimulates pancreatic beta cells to release insulin, helping glucose move from the bloodstream into body tissues.

Metformin primarily reduces glucose production by the liver and improves the body's sensitivity to insulin, allowing glucose to be utilized more effectively.

Voglibose inhibits intestinal alpha-glucosidase enzymes, slowing the breakdown and absorption of carbohydrates. This helps reduce the rapid rise in blood glucose following meals.

Together:

Gliclazide → increases insulin release.
Metformin → decreases hepatic glucose production and improves insulin sensitivity.
Voglibose → slows carbohydrate digestion and reduces post-meal glucose spikes.

Side Effects

Possible side effects may include:

  • Nausea
  • Diarrhea
  • Abdominal discomfort
  • Bloating
  • Flatulence
  • Reduced appetite
  • Headache
  • Dizziness
  • Low blood sugar

Gastrointestinal symptoms may occur because of metformin and voglibose and can sometimes improve with continued treatment.

Available Substitute For This Combination

The appropriate alternative depends on the individual's diabetes status and medical history. A doctor may consider metformin alone, other sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, insulin, or other combination therapies.

Do not substitute or discontinue GLICLAGLAZE TRIO 40/0.3 without medical advice.

Dosage Guidelines For GLICLAGLAZE TRIO 40/0.3

Take GLICLAGLAZE TRIO 40/0.3 exactly as prescribed by your doctor.

  • Follow the prescribed dose and schedule.
  • Take it with meals when directed.
  • Avoid unnecessarily skipping meals because gliclazide can cause low blood sugar.
  • Do not double a dose after a missed tablet unless instructed.
  • Monitor blood glucose according to medical advice.
  • Continue the recommended diet and exercise plan.

Precautions & Warnings

Tell your healthcare professional if you have kidney disease, liver disease, recurrent hypoglycemia, severe infection, dehydration, or excessive alcohol consumption. Also inform your doctor before surgery or certain imaging procedures involving iodinated contrast.

Kidney function is particularly important with metformin-containing medicines. Inform your healthcare provider about all medicines and supplements you take to identify possible interactions and avoid excessive glucose lowering.

Conclusion

GLICLAGLAZE TRIO 40/0.3 by Steris Healthcare combines Gliclazide IP 40 mg, Metformin Hydrochloride IP 500 mg, and Voglibose IP 0.3 mg to provide complementary blood-glucose-lowering effects for appropriate patients with type 2 diabetes.

Gliclazide supports insulin secretion, metformin reduces liver glucose production and improves insulin sensitivity, and voglibose helps control post-meal glucose rises. The medicine should be used only as prescribed and alongside appropriate nutrition, physical activity, glucose monitoring, and regular medical follow-up.

Comments

Post a Comment

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 Healthcare is one of the most significant sectors influencing the well-being of individuals and communities. As medical science advances, the demand for reliable pharmaceutical products continues to grow. Patients, healthcare professionals, and medical institutions all depend on high-quality medicines that meet strict standards of safety and effectiveness. Pharmaceutical companies play a vital role in ensuring these products are developed, manufactured, and delivered responsibly. Steris Healthcare is committed to supporting better healthcare by providing quality pharmaceutical products designed to improve patient outcomes. Guided by innovation, integrity, and continuous improvement, the company strives to meet the evolving needs of the healthcare industry while maintaining high standards of quality and customer satisfaction. A Vision for Better Healthcare Every successful healthcare organization begins with a clear vision. Steris Healthcare believes that quality medicines and de...
Read more

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness

Image
  N-Acetyl L-Cysteine (NAC), Pine Bark Extract & Resveratrol Tablets: Ingredients and Health Benefits Today’s lifestyle in India has changed a lot. Long working hours, stress, pollution, processed food, and lack of physical activity are affecting overall health. Many people feel tired, low on energy, or struggle with metabolic and hormonal balance tablet . One of the main reasons behind this is oxidative stress. Oxidative stress happens when harmful molecules called free radicals damage the body’s cells. Over time, this may affect immunity, liver health, heart health, skin, and overall wellness.  STYLECYSTIN ENDO is a specially designed antioxidant tablet that contains N-Acetyl L-Cysteine (NAC), Pine Bark Extract, and Resveratrol . This powerful combination supports cellular protection, improves antioxidant levels, and promotes better internal balance. It is commonly recommended as supportive therapy in metabolic conditions, women’s health concerns, and lifestyle-related ...
Read more
Megestrol Acetate 160 mg: MAGRAL 160 Uses, Benefits & Safety MAGRAL 160 contains Megestrol Acetate 160 mg and is marketed by Steris Healthcare . Megestrol acetate is a synthetic progestin that is used in specific clinical situations, particularly for managing anorexia, cachexia, or significant unexplained weight loss associated with advanced cancer or AIDS , depending on the approved indication and medical judgment. It is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Megestrol acetate is not a general-purpose appetite booster or routine weight-gain medicine. Before treatment, the underlying reason for poor appetite or weight loss should be evaluated. What is MAGRAL 160 For? MAGRAL 160 may be prescribed when significant appetite loss or involuntary weight loss occurs in certain serious medical conditions. Megestrol acetate can help increase appetite and may contribute to weight gain in appropriately selected patients. Th...
Read more